PLANO, Texas, Sept. 25, 2017 -- Denbury Resources Inc. (NYSE:DNR) (“Denbury” or the “Company”) today announced that Chris Kendall, President and Chief Executive Officer, will present at the Johnson Rice 2017 Energy Conference on Wednesday, September 27, 2017, at 8:00 a.m. Central Time. An updated presentation for the conference will be posted to the Company’s website the morning of Tuesday, September 26, 2017, and a link to the live webcast of the presentation will be available in the investor relations section of the Company’s website at www.denbury.com.
Denbury is an independent oil and natural gas company with operations focused in two key operating areas: the Gulf Coast and Rocky Mountain regions. The Company’s goal is to increase the value of its properties through a combination of exploitation, drilling and proven engineering extraction practices, with the most significant emphasis relating to CO2 enhanced oil recovery operations. For more information about Denbury, please visit www.denbury.com.
DENBURY CONTACTS:
Mark C. Allen, Senior Vice President and Chief Financial Officer, 972.673.2000
John Mayer, Investor Relations, 972.673.2383


Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Nike Stock Jumps After Apple CEO Tim Cook Buys $2.9M Worth of Shares
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Waymo Plans Safety and Emergency Response Upgrades After San Francisco Robotaxi Disruptions
Eli Lilly and Novo Nordisk Battle for India’s Fast-Growing Obesity Drug Market
DOJ Reaches Settlement With Blackstone’s LivCor Over Alleged Rent Price-Fixing
South Korean Court Clears Korea Zinc’s $7.4 Billion U.S. Smelter Project, Shares Surge
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
John Carreyrou Sues Major AI Firms Over Alleged Copyrighted Book Use in AI Training
Warner Bros. Discovery Shares Slide Amid Report of Potential Paramount Skydance Lawsuit
FDA Approves Mitapivat for Anemia in Thalassemia Patients
FTC Praises Instacart for Ending AI Pricing Tests After $60M Settlement
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
Italy Fines Apple €98.6 Million Over App Store Dominance
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
TSMC Honors Japanese Chip Equipment Makers With 2025 Supplier Awards 



